📰 Between Apr News
Between Apr News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Between Apr. Real-time updates on events, politics, business and more.
April 13, 2024
1. Live birth rates after first embryo transfer were similar between intracytoplasmic sperm injection and conventional in-vitro fertilization groups. 2. The incidence of neonatal deaths was rare and comparable in both groups. Evidence Rating Level: 1 (Excellent) Study Rundown: The use of intracytoplasmic sperm injection (ICSI) has expanded from treating severe male infertility to addressing
March 29, 2024
1. The R21/Matrix-M vaccine had a high 12-month efficacy across seasonal and standard sites. 2. The reduction in malarial infection rates was 4 times greater at seasonal sites compared to standard sites. Evidence Rating Level: 1 (Excellent) Study Rundown: The R21/Matrix-M vaccine is a novel vaccine for the prevention of Plasmodium falciparum infection in regions
February 6, 2024
1. Best practices centred around supportive decisions and ultrasound evaluation of risk significantly reduced perinatal and maternal morbidity. 2. No difference in perinatal or maternal morbidity was seen between groups among patients who underwent elective Caesarean delivery. Evidence Rating Level: 1 (Excellent) Study Rundown: Women with a prior cesarean section face the dilemma of choosing
November 30, 2023
1. Mean HbA1c reduction at 26 weeks was comparable in the weekly icodec and daily degludec groups. 2. The risk of hypoglycemia was significantly higher among patients taking weekly insulin icodec compared to those taking daily insulin degludec. Evidence Rating Level: 1 (Excellent) Study Rundown: First-line therapy for type 1 diabetes includes a combination of
October 10, 2023
1. Recurrence-free survival was significantly different between the adjuvant everolimus and placebo groups. 2. Grade 3 or higher adverse events were more frequent in the everolimus group with oral mucositis being the most reported within this treatment arm. Evidence Rating Level: 1 (Excellent) Study Rundown: Patients with renal cell carcinoma face a high risk of
July 21, 2023
1. Patients assigned to hemodynamic monitoring reported improved quality of life than those receiving contemporary guideline-directed medical therapy. 2. The rate of hospitalizations due to heart failure was reduced by 44% in the hemodynamic monitoring group compared to the control. Evidence Rating Level: 1 (Excellent) Study Rundown: In patients with heart failure, hemodynamic congestion may precede
July 6, 2023
1. Patients assigned to hemodynamic monitoring reported improved quality of life than those receiving contemporary guideline-directed medical therapy. 2. The rate of hospitalizations due to heart failure was reduced by 44% in the hemodynamic monitoring group compared to the control. Evidence Rating Level: 1 (Excellent) Study Rundown: In patients with heart failure, hemodynamic congestion may
June 10, 2023
1. Patients in the sleeve gastrectomy and Roux-en-Y bypass groups reported significantly greater resolution of NASH compared to those in the lifestyle plus medical intervention group. 2. 70% of patients in the surgical group achieved NASH resolution at the 1-year follow-up. Evidence Rating Level: 1 (Excellent) Study Rundown: Non-alcoholic steatohepatitis (NASH) is a form of
April 27, 2023
Motilal Oswal recommended Neutral rating on SAIL with a target price of Rs 85 in its research report dated April 26, 2023.